The urobiome, urinary tract infections, and the need for alternative therapeutics

Microb Pathog. 2021 Dec;161(Pt B):105295. doi: 10.1016/j.micpath.2021.105295. Epub 2021 Nov 18.

Abstract

Improvements in bacterial culturing and DNA sequencing techniques have revealed a diverse, and hitherto unknown, urinary tract microbiome (urobiome). The potential role of this microbial community in contributing to health and disease, particularly in the context of urinary tract infections (UTIs) is of significant clinical importance. However, while several studies have confirmed the existence of a core urobiome, the role of its constituent microbes is not yet fully understood, particularly in the context of health and disease. Herein, we review the current state of the art, concluding that the urobiome represents an important component of the body's innate immune defences, and a potentially rich resource for the development of alternative treatment and control strategies for UTIs.

Keywords: Antibiotic resistance; Bacteriocins; UPEC; UTIs; Urobiome; Uropathogenic E. coli; Vaccines; Virulence factors.

Publication types

  • Review

MeSH terms

  • Escherichia coli Infections*
  • Humans
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract*
  • Uropathogenic Escherichia coli*